Company Profiles

driven by the PitchBook Platform

BioVascular

BioVascular
2005 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series C LATEST DEAL TYPE
$10.9M LATEST DEAL AMOUNT
$19M TOTAL AMOUNT RAISED
Description

Developer of drugs and devices for the control of platelet mediated cardiovascular diseases. The company conducts human clinical trials of saratin for use in hemodialysis access graft and peripheral artery grafts to reduce intimal hyperplasia, which can lead to failure of the graft.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
12230 El Camino Real
Suite 100
San Diego, CA 92130
United States

+1 (858) 455-5000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioVascular’s full profile, request a free trial.

BioVascular Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 07-Feb-2008 $10.9M $19M 000.00 Completed Startup
2. Early Stage VC (Series B) 01-Nov-2007 00.000 00.000 000.00 Completed Startup
1. Early Stage VC (Series A) 11-Jul-2005 $4M $4M $15M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

BioVascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series B 0,000,000 00.000000 00 00 00 00 00 00.000
Series A 4,000,000 $0.001000 8% $1 $1 1x $1 14.6%
To view this company’s complete Cap Table request access »

BioVascular Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BB Biotech Asset Manager Minority 000 0000 000000 0
Merck Capital Ventures Corporate Venture Capital Minority 000 0000 000000 0

BioVascular Executive Team (2)

Name Title Board
Seat
Contact
Info
John Parrish Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Christopher Bussineau Ph.D Vice President, Pharmaceutical Operations

BioVascular Board Members (6)

Name Representing Role Since Contact
Info
Arno Hartmann Ph.D Self Board Member 000 0000
John Parrish Ph.D BioVascular Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Martin M├╝nchbach Ph.D Self Board Member 000 0000
Stephen Hanson Ph.D Self Board Member 000 0000

2 Former Board Members

You’re viewing 4 of 6 board members. Get the full list »